Brie M Chun

4PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 16, 2025
Response to a novel type II RAF inhibitor in diffuse leptomeningeal glioneuronal tumor with BRAF fusion.

Brie M Chun, Sandra Youngworth, Vicki Abtin

|Jun 21, 2023
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.

David B Page, Joanna Pucilowska, Brie Chun

|Mar 22, 2023
Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer.

Malinda T West, Shaun M Goodyear, Evthokia A Hobbs

|Jan 28, 2022
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.

Brie Chun, Joanna Pucilowska, ShuChing Chang

Pageof 1

Frequent Collaborators

2 joint publications

William L Redmond

2 joint publications

David B Page

1 joint publications

Malinda T West

1 joint publications

Shaun M Goodyear